• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.67 0.05
(0.05%)
EUR-INR
111.76 0.57
(0.51%)
GBP-INR
130.35 0.55
(0.42%)
JPY-INR
0.60 0.00
(0.11%)

EQUITY - MARKET SCREENER

Accedere Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
531533
INE578B01015
11.3775025
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
46.24
38.81
EPS(TTM)
Face Value()
Div & Yield %
1.7
10
0
 

Valiant Laboratories consolidated net profit rises 151.43% in the March 2026 quarter
May 15,2026
Net profit of Valiant Laboratories rose 151.43% to Rs 1.76 crore in the quarter ended March 2026 as against Rs 0.70 crore during the previous quarter ended March 2025. Sales rose 59.16% to Rs 91.98 crore in the quarter ended March 2026 as against Rs 57.79 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.27 crore in the year ended March 2026 as against net loss of Rs 2.20 crore during the previous year ended March 2025. Sales rose 78.04% to Rs 237.47 crore in the year ended March 2026 as against Rs 133.38 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales91.9857.79 59 237.47133.38 78
OPM %5.236.61 -2.69-3.50 -
PBDT3.971.46 172 6.810.58 1074
PBT1.050.94 12 0.77-1.51 LP
NP1.760.70 151 -3.27-2.20 -49